Flowchart of the PITA (Pharmacogenetics for Individualized Tricyclic Antidepressant [TCA]) Study
The reference group consisted of nonrandomized patients with a cytochrome P450 2D6 isozyme (CYP2D6) normal metabolizer phenotype receiving usual treatment. PIT indicates pharmacogenetics-informed treatment; TAU, treatment as usual.